pleas
cite
articl
mu
mirza
froeyen
structur
elucid
vital
protein
comput
method
reveal
potenti
drug
candid
main
proteas
polymeras
helicas
journal
pharmaceut
analysi
doi
http
doi
integr
structurebas
approach
identifi
potenti
inhibitor
protein
structur
import
bind
site
residu
elucid
energi
decomposit
analysi
structur
insight
provid
import
inform
futur
drug
develop
recent
emerg
caus
major
outbreak
coronaviru
diseas
instig
widespread
fear
threaten
global
health
secur
date
licens
antivir
drug
vaccin
avail
although
sever
clinic
trial
underway
test
possibl
therapi
urgenc
situat
comput
drug
discoveri
method
provid
altern
tiresom
highthroughput
screen
particularli
hittoleadoptim
stage
identif
small
molecul
specif
target
viral
replic
apparatu
indic
highest
potenti
toward
antivir
drug
discoveri
work
present
potenti
compound
specif
target
vital
protein
includ
main
proteas
rna
polymeras
helicas
integr
virtual
screen
molecular
dynam
simul
approach
led
identif
potenti
bind
mode
favour
molecular
interact
profil
correspond
compound
moreov
identif
structur
import
bind
site
residu
conserv
motif
locat
insid
activ
site
highlight
rel
import
ligand
bind
base
residu
energi
decomposit
analysi
although
current
studi
lack
experiment
valid
structur
inform
obtain
comput
studi
pave
way
design
target
inhibitor
combat
outbreak
ongo
outbreak
coronaviru
diseas
april
claim
live
global
declar
pandem
belong
coronavirus
famili
seventh
known
human
coronaviru
hcov
famili
merscov
sarscov
current
licens
drug
vaccin
avail
although
sever
clinic
trial
progress
test
possibl
therapi
treatment
focus
allevi
symptom
may
includ
dri
cough
fever
pneumonia
follow
sar
outbreak
exist
antivir
includ
nine
proteas
inhibitor
nelfinavir
block
replic
lowest
concentr
ec
cc
si
follow
antivir
effici
sever
fdaapprov
drug
report
includ
remdesivir
gilead
chloroquin
clinic
isol
vitro
show
potenti
inhibit
lowmicromolar
concentr
efficaci
remdesivir
evid
recent
recoveri
us
patient
infect
intraven
treatment
chloroquin
evalu
openlabel
trial
moreov
ivermectin
broad
spectrum
antiparasit
agent
report
vitro
activ
reduct
model
verohslam
cell
infect
isol
other
includ
nafamostat
nitazoxanid
favipiravir
recent
hydroxychloroquin
shown
effect
patient
effici
reportedli
reinforc
azithromycin
viru
elimin
despit
wellcontrol
random
clinic
evid
support
azithromycin
therapi
cov
singlestrand
positivesens
rna
ssrna
virus
tail
genom
contain
least
six
open
read
frame
orf
first
orf
twothird
whole
genom
length
encod
nonstructur
protein
orf
near
genom
encod
four
main
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
protein
among
nonstructur
protein
known
play
vital
role
cov
replic
structur
protein
howev
import
virion
assembl
well
caus
cov
infect
addit
specif
structur
accessori
protein
protein
also
encod
cov
genom
maintain
nucleotid
ident
origin
sar
epidem
virus
address
current
outbreak
develop
widespectrum
inhibitor
covassoci
diseas
attract
strategi
howev
approach
requir
identif
conserv
target
region
within
entir
coronaviru
genu
contrari
structur
protein
includ
e
n
protein
among
differ
cov
consider
variat
report
therefor
ad
complex
toward
identif
inhibitor
subsequ
rnadepend
rna
polymeras
rdrp
helicas
main
proteas
mpro
chymotrypsinlik
proteas
constitut
highli
conserv
region
nonstructur
protein
among
coronavirus
target
although
structur
data
avail
protein
start
studi
howev
consid
high
sequenc
similar
protein
model
ration
drug
design
later
lead
downstream
modif
drug
lead
current
studi
focuss
structur
elucid
critic
import
polymeras
helicas
mpro
togeth
virtual
screen
vs
studi
report
potenti
hit
identifi
integr
vs
molecular
dynam
simul
approach
although
current
studi
lack
experiment
valid
propos
hit
howev
structur
inform
along
identifi
potenti
hit
may
serv
start
point
structureguid
drug
discoveri
homolog
model
key
protein
includ
mpro
polymeras
helicas
design
use
swissmodel
resolv
crystal
structur
avail
time
studi
later
molecular
dock
studi
recent
report
cocryst
mpro
structur
util
pdb
id
templat
highest
ident
select
respect
model
gener
residu
insid
bind
pocket
predict
use
analyt
tool
coach
metaserv
compar
superimpos
variou
close
relat
xray
resolv
cocrystal
structur
bound
inhibitor
gener
homolog
model
refin
use
molecular
dynam
md
simul
remov
steric
clash
optim
sidechain
geometri
simul
packag
util
unrestrain
md
simul
use
amber
forc
field
stepwis
minim
equilibr
protocol
perform
detail
si
solvat
system
model
explicit
water
molecul
submit
product
run
ns
constant
temperatur
bar
pressur
protein
backbon
conform
analyz
use
cpptraj
modul
evalu
ramachandhran
plot
favour
conform
select
virtual
screen
small
molecul
dataset
smile
format
download
zinc
databas
upload
mcule
fulli
autom
drug
discoveri
platform
virtual
screen
pipelin
establish
use
druglik
filter
divers
select
implement
reduc
size
librari
maxim
coverag
chemic
space
time
procedur
exclud
closest
analogu
base
tanimoto
similar
coeffici
maxim
divers
potenti
activ
scaffold
identifi
huge
dataset
thorough
analysi
bind
site
residu
perform
prior
dock
depict
coach
structur
comparison
dock
grid
set
cover
key
bind
site
residu
reduc
search
space
ligand
optim
autom
inbuilt
autodock
ad
vina
dock
engin
util
screen
compos
dock
librari
use
gradient
optim
method
local
optim
process
rank
best
pose
effici
individu
compound
dock
librari
togeth
mcule
databas
dock
iter
respect
bind
pocket
repres
mpro
polymeras
helicas
structur
compound
rank
base
vina
empir
score
function
approxim
ligand
bind
affin
kcalmol
sinc
variou
dock
program
estim
real
bind
affin
therefor
test
differ
dock
program
add
reliabl
top
hit
obtain
first
round
dock
evalu
glide
extra
precis
dock
mode
glide
xp
implement
maestro
model
packag
trial
version
util
studi
protein
prepar
use
protein
prepar
wizard
ad
hydrogen
atom
miss
side
chain
short
minim
hydrogen
atom
carri
use
opl
forc
field
select
ligand
rank
autodock
vina
prepar
use
ligprep
describ
previous
grid
box
gener
dimens
cover
predict
activ
site
residu
top
hit
select
extens
postdock
analysi
compar
bind
pose
predict
ad
vina
glide
gain
understand
predict
molecular
interact
best
dock
complex
analys
period
md
simul
use
amber
simul
packag
antechamb
modul
use
gener
atom
partial
charg
select
hit
studi
previous
report
md
simul
protocol
follow
detail
si
gain
ration
insight
differ
bind
mode
residu
contribut
molecular
mechanicsgener
born
solvent
area
mmgbsa
method
employ
total
bind
free
energi
kcalmol
calcul
mmgbsa
approach
well
detail
bind
free
energi
calcul
antivir
inhibitor
silico
model
work
initi
analys
wuhan
seafood
market
pneumonia
viru
genom
ncbi
genom
id
recent
deposit
wu
et
al
current
work
polyprotein
sequenc
genbank
id
consid
total
amino
acid
order
locat
potenti
mpro
sequenc
multipl
sequenc
align
perform
known
sarscov
protein
uniprot
id
correspond
region
genom
identifi
base
sequenc
ident
similar
score
sequenc
align
reveal
polymeras
helicas
mpro
share
high
similar
sar
homolog
model
perform
use
swissmodel
gener
model
valid
accordingli
sarscov
protein
deposit
protein
data
bank
pdb
indic
ident
sarscov
mpro
result
high
sequenc
similar
homolog
model
reveal
strikingli
conserv
overal
architectur
superimposit
rdrp
helicas
mpro
sarscov
protein
demonstr
high
structur
similar
root
mean
squar
deviat
rmsd
valu
respect
model
valid
use
procheck
indic
mpro
rdrp
residu
ramachandran
favour
region
rotam
outlier
helicas
indic
outlier
model
refin
md
simul
compar
templat
avail
crystal
structur
mpro
complex
peptid
homolog
model
also
compar
less
rmsd
found
indic
reliabl
gener
model
subtl
differ
figur
overal
polymeras
helicas
model
reliabl
enough
perform
virtual
screen
mpro
cocryst
structur
util
model
reveal
conserv
featur
especi
function
region
due
strikingli
similar
protein
conform
howev
structur
featur
elucid
togeth
identif
inhibitor
bind
site
protein
shown
figur
also
reveal
similar
posit
subsit
especi
activ
site
close
crucial
substrat
recognit
along
substratebind
pocket
dock
grid
form
around
subsit
virtual
screen
take
cocryst
mpro
top
hit
identifi
base
dock
score
polymeras
predict
contain
amino
acid
locat
polyprotein
aa
compris
ntermin
aa
polymeras
domain
aa
compar
sarscov
polymeras
domain
adopt
structur
resembl
cup
right
hand
like
polymeras
nsp
polymeras
compris
finger
aa
palm
aa
thumb
subdomain
aa
figur
similar
mer
finger
thumb
subdomain
ncovrdrp
contact
configur
rdrp
activ
site
centr
substrat
access
templat
entri
templateprim
exit
ntp
tunnel
alongsid
also
reveal
seven
conserv
motif
g
arrang
polymeras
activ
site
chamber
involv
templat
nucleotid
bind
catalysi
bind
site
analys
superimposit
elong
complex
polioviru
bound
ctpmn
crystal
structur
japanes
enceph
rdrp
complex
atp
dock
grid
form
around
polymeras
activ
site
chamber
cover
conserv
motif
g
potenti
hit
identifi
predict
contain
amino
acid
locat
orflab
polyprotein
aa
like
sar
overal
structur
adopt
triangular
pyramid
shape
compris
five
domain
among
two
recalik
domain
aa
aa
domain
aa
form
triangular
base
ntermin
zinc
bind
domain
zbd
aa
stalk
domain
aa
connect
zbd
domain
arrang
apex
pyramid
figur
small
molecul
abl
inhibit
ntpase
activ
interfer
atp
bind
may
serv
ideal
strategi
develop
inhibitor
reveal
similar
conserv
ntpase
activ
site
residu
includ
present
residu
cluster
togeth
cleft
locat
base
domain
dock
grid
form
locat
bound
adp
crystal
yeast
top
hit
identifi
stepwis
structurebas
virtual
screen
pipelin
adopt
consid
put
bind
site
mpro
polymeras
helicas
ident
potenti
hit
describ
previou
studi
identifi
potenti
hit
target
subject
silico
admet
absorpt
distribut
metabol
elimin
toxic
predict
includ
druglik
toxic
potenti
filter
remov
substanti
hit
exhibit
poor
admet
due
inhibitori
effect
renal
organ
cation
transport
isozym
larg
subset
hit
found
contain
highrisk
chemic
group
like
epoxid
quinon
potenti
hit
target
lowest
dock
energi
analys
bind
pose
insid
bind
site
care
inspect
best
hit
base
ad
vina
predict
bind
energi
redock
glide
best
dock
complex
process
md
simul
mmgbsa
method
employ
analys
electrostat
vdw
energi
contribut
toward
total
free
energi
bind
mdsimul
complex
indic
protein
backbon
stabil
last
ns
product
run
consid
molecular
interact
analysi
base
molecular
interact
bind
free
energi
calcul
subsequ
screen
result
hit
mpro
respect
detail
admet
profil
compound
tabul
tabl
estim
swissadm
server
top
hit
ad
vina
glide
xpscore
togeth
contribut
electrostat
ele
van
der
waal
vdw
solutesolv
energi
np
p
toward
total
bind
free
energi
tol
estim
ambermmgbsa
modul
tabul
tabl
energi
contribut
calcul
kcalmol
note
tol
sum
molecular
mechan
energi
mm
solvat
free
energi
sol
mm
sol
divid
intern
energi
int
electrostat
energi
ele
van
der
waal
vdw
energi
ga
phase
polar
p
nonpolar
np
contribut
solvat
free
energi
unit
paramet
calcul
kcalmol
valid
dock
protocol
cocryst
peptid
remov
redock
substratebind
site
mpro
use
dock
paramet
gener
redock
pose
quit
similar
cocryst
conform
figur
toprank
mpro
hit
filter
base
interact
catalyt
dyad
least
one
hbond
either
strong
vdw
interact
total
compound
analys
ns
md
simul
base
stabil
least
last
ns
mmgbsa
calcul
perform
stabl
complex
among
top
hit
total
bind
free
energi
tol
promis
exhibit
tol
tabl
indepth
molecular
interact
analysi
md
simul
unveil
signific
find
respect
mprosubsit
figur
perresidu
decomposit
display
figur
among
compound
show
consensu
featur
pentacycl
moieti
anchor
right
insid
subsit
form
hbond
figur
favour
residu
energi
contribut
evid
hbond
form
chemic
structur
represent
compound
display
connect
interact
structur
moieti
bind
pocket
subsit
figur
rdrp
hit
select
base
establish
hbond
conserv
motif
especi
signatur
motif
c
sdd
experiment
evalu
alter
polymeras
activ
support
variou
mutat
studi
total
hit
analys
md
simul
complex
stabl
rmsd
process
mmgbsa
bind
free
energi
calcul
among
hit
show
promis
tol
kcalmol
mainli
interact
hbond
thu
contribut
electrostat
tabl
complex
remain
stabl
throughout
ns
md
simul
figur
care
molecular
inspect
md
reveal
similar
conform
compound
found
interact
extens
conserv
motif
figur
establish
three
hbond
residu
belong
signatur
motif
c
motif
motif
e
figur
form
five
hbond
motif
motif
b
motif
c
motif
figur
wherea
interact
mainli
residu
motif
motif
f
motif
c
four
hbond
figur
togeth
variou
residu
also
contribut
strong
hydrophob
interact
instanc
establish
strong
stalk
interact
termin
difluorobenzen
perresidu
bind
energi
decomposit
analysi
reveal
key
role
import
residu
locat
conserv
polymeras
motif
figur
includ
residu
motif
f
exhibit
favour
tol
kcalmol
kcalmol
kcalmol
ii
conserv
aspart
residu
motif
c
iii
conserv
serin
residu
motif
b
motif
c
motif
among
motif
c
exhibit
signific
bind
free
energi
compound
rang
kcalmol
kcalmol
residu
interact
electrostat
end
long
run
simul
process
xray
resolv
polymeras
structur
deposit
compar
crystal
structur
found
deviat
figur
support
md
simul
homolog
model
also
show
consensu
rmsd
period
moreov
conform
show
ident
bind
mode
dock
insid
polymeras
activ
site
crystal
structur
addit
bind
mode
molecular
interact
profil
agre
report
compar
bind
model
remdesivir
sofosbuvir
diphosph
hcvrdrp
polymeras
figur
helicas
top
hit
select
base
signific
interact
six
key
residu
includ
neighbour
residu
involv
ntp
hydrolysi
ns
md
simul
top
rank
complex
led
identif
best
compound
base
consider
interact
key
residu
demonstr
favour
mmgbsa
bind
free
energi
tabl
complex
remain
stabl
throughout
ns
md
simul
except
fluctuat
start
adopt
favour
conform
insid
bind
pocket
figur
superimposit
show
overal
bind
mode
identifi
compound
figur
two
dimension
interact
plot
yeast
reveal
network
hbond
establish
phosphat
group
also
conserv
ncovhelicas
figur
mmgbsa
method
estim
favour
tol
kcalmol
kcalmol
kcalmol
except
kcalmol
contribut
mainli
vdw
energi
nonpolar
solvat
energi
also
slightli
contribut
tabl
indepth
molecular
analysi
show
signific
mmgbsa
total
energi
indic
hbond
establish
termin
region
interact
mainli
side
chain
figur
residu
also
found
conserv
complex
except
perresidu
energi
decomposit
analysi
indic
major
contribut
domain
domain
indic
kcalmol
bind
energi
four
compound
togeth
also
contribut
total
free
energi
bind
figur
comput
method
offer
immedi
scientif
sound
basi
design
highli
specif
inhibitor
import
viral
protein
give
aid
antivir
drug
discoveri
recent
structur
model
effort
predict
repurpos
drug
vital
protein
includ
antibacteri
antifung
antihiv
drug
flavonoid
differ
sourc
current
studi
brief
structur
elucid
perform
togeth
reveal
strikingli
similar
featur
compar
crystal
structur
sarscovrdrp
helicas
viral
protein
play
crucial
role
viral
life
cycl
consid
among
popular
strategi
antivir
therapeut
structur
analys
reveal
substratebind
pocket
sarscovmpro
activ
site
rdrp
ntpase
bind
pocket
helicas
highli
conserv
lead
concept
widespectrum
inhibitor
target
cov
furthermor
extens
sbv
procedur
led
identif
potenti
hit
target
assess
md
simul
mmgbsa
per
residu
energi
decomposit
divulg
rel
import
amino
acid
involv
bind
support
contribut
differ
compon
bind
free
energi
overal
hit
found
interact
catalyt
dyad
togeth
residu
locat
subsit
substrat
bind
pocket
mutat
studi
result
complet
loss
enzymat
activ
confirm
role
catalyt
dyad
substratebind
pocket
catalyt
dyad
residu
highli
conserv
residu
display
rel
import
ligand
bind
suggest
possibl
inhibitor
design
target
region
mpro
case
indepth
interact
analysi
insid
conserv
motif
figur
reveal
function
import
aspart
residu
motif
motif
c
togeth
conserv
arginin
residu
motif
f
motif
c
found
highli
interact
compound
among
motif
c
strikingli
conserv
aspart
residu
bind
dival
metal
ion
necessari
catalyt
activ
moreov
import
aspart
residu
rdrp
support
variou
mutat
studi
suggest
conserv
bind
featur
along
side
chain
line
deep
bind
pocket
ncovrdrp
thu
enhanc
anchor
inhibitori
molecul
structur
inform
ntpase
activ
site
obtain
superimpos
sarshelicas
divulg
locat
conserv
residu
identifi
hit
posit
similarli
refer
interact
network
report
cocryst
adp
figur
activ
site
side
chain
activ
particip
hbond
conserv
alanin
residu
contribut
substanti
toward
total
bind
free
energi
moreov
import
residu
alreadi
highlight
mutat
studi
moreov
identifi
compound
exhibit
promis
admet
properti
none
compound
found
contain
highrisk
chemic
group
drug
candid
poor
admet
might
lead
toxic
metabolit
unabl
cross
membran
predict
solubl
estim
within
accept
rang
compound
predict
noninhibitor
cytochrom
isozym
play
vital
role
drug
metabol
inhibit
enzym
lead
toxic
poor
excret
liver
moreov
compound
found
novel
report
elsewher
antivir
activ
among
variou
hit
identifi
rdrp
recent
report
panjanu
kinas
inhibitor
clinic
candid
potenti
role
treatment
inflammatori
diseas
lung
henc
could
ideal
reduc
inflammatori
activ
pathogen
epidem
lung
inflamm
observ
sar
mer
outbreak
conclus
comprehens
studi
present
integr
comput
approach
toward
identif
novel
inhibitor
area
antincov
treatment
start
point
warrant
vitro
test
evalu
compound
efficaci
indepth
structur
elucid
interact
residu
togeth
dynam
conform
adopt
period
md
simul
identifi
compound
offer
way
design
widespectrum
select
inhibitor
hcov
